Hsp90, the concertmaster: Tuning transcription

Frontiers in Oncology

Volumn 5, Issue APR, 2015, Pages

  Khurana, Nidhi ^a   Bhattacharyya, Sunanda ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

Cancer; Chromatin modifiers; Hsp90; Transcription; Transcription factors

Indexed keywords

HEAT SHOCK PROTEIN 90; TRANSCRIPTION FACTOR;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL SURVIVAL; CELLULAR STRESS RESPONSE; DNA METHYLATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; INFLAMMATION; TRANSCRIPTION REGULATION;

EID: 84935050175     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00100     Document Type: Article

References (68)

1. Gabai VL, Kabakov AE. Induction of heat-shock protein synthesis and thermotolerance in EL-4 ascites tumor cells by transient ATP depletion after ischemic stress. Exp Mol Pathol (1994) 60:88-99. doi: 10.1006/exmp.1994.1008
2. Protti MP, Heltai S, Bellone M, Ferrarini M, Manfredi AA, Rugarli C. Constitutive expression of the heat-shock protein 72 kDa in human melanoma cells. Cancer Lett (1994) 85:211-6. doi:10.1016/0304-3835(94)90277-1
3. Franzen B, Linder S, Alaiya AA, Eriksson E, Fujioka K, Bergman AC, et al. Analysis of polypeptide expression in benign and malignant human breast lesions. Electrophoresis (1997) 18:582-7. doi:10.1002/elps.1150180341
4. Ehrenfried JA, Herron BE, Townsend CM Jr, Evers BM. Heat shock proteins are differentially expressed in human gastrointestinal cancers. Surg Oncol (1995) 4:197-203. doi:10.1016/S0960-7404(10)80036-2
5. Gress TM, Muller-Pillasch F, Weber C, Lerch MM, Friess H, Buchler M, et al. Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res (1994) 54:547-51.
6. Mileo AM, Fanuele M, Battaglia F, Scambia G, Benedetti-Panici P, Mancus S, et al. Selective overexpression of mRNA coding for 90 KDa stress-protein in human ovarian cancer. Anticancer Res (1990) 10(903-906):1990.
7. Nanbu K, Konishi I, Komatsu T, Mandai M, Yamamoto S, Kuroda H, et al. Expression of heat-shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. Cancer (1996) 77:330-8. doi:10.1002/(SICI)1097-0142(19960115)77:2<330::AID-CNCR16>3.0.CO;2-2
8. Whitesell L, Sutphin PD, Pulcini EJ, Martinez JD, Cook PH. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol (1998) 18:1517-24.
9. Morcillo G, Diez JL, Carbajal ME, Tanguay RM. HSP90 associates with specific heat shock puffs (hsrω) in polytene chromosomes of Drosophila and Chironomus. Chromosoma (1993) 102:648-59. doi:10.1007/BF00352313
10. Ni L, Yang CS, Gioeli D, Frierson H, Toft DO, Paschal BM. FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells. Mol Cell Biol (2010) 30:1243-53. doi:10.1128/MCB.01891-08
11. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med (2004) 10:33-9. doi:10.1038/nm972
12. Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res (2002) 62:1008-13.
13. Saporita AJ, Ai J, Wang Z. The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells. Prostate (2007) 67:509-20. doi:10.1002/pros.20541
14. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity (2000) 13:199-212. doi:10.1016/S1074-7613(00)00020-0
15. Wang SA, Chuang JY, Yeh SH, Wang YT, Liu YW, Chang WC, et al. Heat shock protein 90 is important for Sp1 stability during mitosis. J Mol Biol (2009) 387:1106-19. doi:10.1016/j.jmb.2009.02.040
16. Sawarkar R, Paro R. Hsp90@ chromatin. nucleus: an emerging hub of a networker. Trends Cell Biol (2013) 23:193-201. doi:10.1016/j.tcb.2012.11.007
17. Porter JR, Fritz CC, Depew KM. Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy. Curr Opin Chem Biol (2010) 14:412-20. doi:10.1016/j.cbpa.2010.03.019
18. Jarosz DF, Taipale M, Lindquist S. Protein homeostasis and the phenotypic manifestation of genetic diversity: principles and mechanisms. Annu Rev Genet (2010) 44:189-216. doi:10.1146/annurev.genet.40.110405.090412
19. Zhang H, Burrows F. Targeting multiple signal transduction pathways through inhibition of Hsp90. J Mol Med (2004) 82:488-99. doi:10.1007/s00109-004-0549-9
20. Sato N, Yamamoto T, Sekine Y, Yumioka T, Junicho A, Fuse H, et al. Involvement of heat-shock protein 90 in the interleukin-6-mediated signaling pathway through STAT3. Biochem Biophys Res Commun (2003) 300:847-52. doi:10.1016/S0006-291X(02)02941-8
21. Gilmore TD. Introduction to NF-κB: players, pathways, perspectives. Oncogene (2006) 25:6680-4. doi:10.1038/sj.onc.1209954
22. Wan F, Lenardo MJ. The nuclear signaling of NF-κB: current knowledge, new insights, and future perspectives. Cell Res (2010) 20:24-33. doi:10.1038/cr.2009.137
23. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif (2012) 45:487-98. doi:10.1111/j.1365-2184.2012.00845.x
24. Illidge T, Tolan S. Current treatment approaches for diffuse large B-cell lymphoma. Leuk Lymphoma (2008) 49:663-76. doi:10.1080/10428190701882187
25. Cerchietti LC, Lopes EC, Yang SN, Hatzi K, Bunting KL, Tsikitas LA, et al. A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas. Nat Med (2009) 15:1369-76. doi:10.1038/nm.2059
26. Stark GR, Darnell JE. The JAK-STAT pathway at twenty. Immunity (2012) 36:503-14. doi:10.1016/j.immuni.2012.03.013
27. Li D, Yallowitz A, Ozog L, Marchenko N. A gain-of-function mutant p53-HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress. Cell Death Dis (2014) 5:e1194. doi:10.1038/cddis.2014.158
28. Xia LM, Huang WJ, Wang B, Liu M, Zhang Q, Yan W, et al. Transcriptional up-regulation of FoxM1 in response to hypoxia is mediated by HIF-1. J Cell Biochem (2009) 106:247-56. doi:10.1002/jcb.21996
29. Dai B, Gong A, Jing Z, Aldape KD, Kang SH, Sawaya R, et al. Forkhead box M1 is regulated by heat shock factor 1 and promotes glioma cells survival under heat shock stress. J Biol Chem (2013) 288:1634-42. doi:10.1074/jbc.M112.379362
30. Murata T, Iwata S, Siddiquey MNA, Kanazawa T, Goshima F, Kawashima D, et al. Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma. PLoS One (2013) 8:e63566. doi:10.1371/journal.pone.0063566
31. Sanchez ER. Chaperoning steroidal physiology: lessons from mouse genetic models of Hsp90 and its cochaperones. Biochim Biophys Acta (2012) 1823:722-9. doi:10.1016/j.bbamcr.2011.11.006
32. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumors. Nature (2012) 490:61-70. doi:10.1038/nature11412
33. Shafi AA, Yen AE, Weigel NL. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Pharmacol Ther (2013) 140:223-38. doi:10.1016/j.pharmthera.2013.07.003
34. Kuo PC, Huang CW, Lee CI, Chang HW, Hsieh SW, Chung YP, et al. BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability. Br J Cancer (2015) 112:391-402. doi:10.1038/bjc.2014.603
35. Lin JJ, Hemenway CS. Hsp90 directly modulates the spatial distribution of AF9/MLLT3 and affects target gene expression. J Biol Chem (2010) 285:11966-73. doi:10.1074/jbc.M110.101642
36. Sato A, Nakama K, Watanabe H, Satake A, Yamamoto A, Omi T, et al. Role of activating transcription factor 3 protein ATF3 in necrosis and apoptosis induced by 5-fluoro-2'-deoxyuridine. FEBS J (2014) 281:1892-900. doi:10.1111/febs.12752
37. Tsutsumi S, Neckers L. Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis. Cancer Sci (2007) 98:1536-9. doi:10.1111/j.1349-7006.2007.00561.x
38. Hance MW, Dole K, Gopal U, Bohonowych JE, Jezierska-Drutel A, Neumann CA, et al. Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer. J Biol Chem (2012) 287:37732-44. doi:10.1074/jbc.M112.389015
39. Bohonowych JE, Hance MW, Nolan KD, Defee M, Parsons CH, Isaacs JS. Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment. Prostate (2014) 74:395-407. doi:10.1002/pros.22761
40. Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva FP, Li M, et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol (2004) 6:731-40. doi:10.1038/ncb1151
41. Hamamoto R, Silva FP, Tsuge M, Nishidate T, Katagiri T, Nakamura Y, et al. Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci (2006) 97:113-8. doi:10.1111/j.1349-7006.2006.00146.x
42. Silva FP, Hamamoto R, Kunizaki M, Tsuge M, Nakamura Y, Furukawa Y. Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells. Oncogene (2008) 27:2686-92. doi:10.1038/sj.onc.1210929
43. Brown MA, Foreman K, Harriss J, Das C, Zhu L, Edwards M. C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis. Oncotarget (2015) 6:4005-19.
44. Ruden DM, Xiao L, Garfinkel MD, Lu X. Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstibesterol on uterine development and cancer. Hum Mol Genet (2005) 14:R149-55. doi:10.1093/hmg/ddi103
45. Okayama S, Kopelovich L, Balmus G, Weiss RS, Herbert BS, Dannenberg AJ, et al. p53 protein regulates Hsp90 ATPase activity and thereby Wnt signaling by modulating Aha1 expression. J Biol Chem (2014) 289:6513-25. doi:10.1074/jbc.M113.532523
46. Agoston AT, Argani P, Yegnasubramanian S, De Marzo AM, Ansari-Lari MA, Hicks JL, et al. Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer. J Biol Chem (2005) 280:18302-10. doi:10.1074/jbc.M501675200
47. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, Davidson NE. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res (1994) 54:2552-5.
48. Zhou Q, Atadja P, Davidson NE. Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation. Cancer Biol Ther (2007) 6:64-9. doi:10.4161/cbt.6.1.3549
49. Zhou Q, Agoston AT, Atadja P, Nelson WG, Davidson NE. Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells. Mol Cancer Res (2008) 6:873-83. doi:10.1158/1541-7786.MCR-07-0330
50. Millson SH, Truman AW, King V, Prodromou C, Pearl LH, Piper PW. A two-hybrid screen of the yeast proteome for Hsp90 interactors uncovers a novel Hsp90 chaperone requirement in the activity of a stress-activated mitogen-activated protein kinase, Slt2p (Mpk1p). Eukaryot Cell (2005) 4:849-60. doi:10.1128/EC.4.5.849-860.2005
51. Laskar S, Bhattacharyya MK, Shankar R, Bhattacharyya S. HSP90 controls SIR2 mediated gene silencing. PLoS One (2011) 6:e23406. doi:10.1371/journal.pone.0023406
52. Laskar S, K S, Bhattacharyya MK, Nair AS, Dhar P, Bhattacharyya S. Heat stress induced Cup9 dependent transcriptional regulation of Sir2. Mol Cell Biol (2015) 35:437-50. doi:10.1128/MCB.01046-14
53. Zhao R, Davey M, Hsu YC, Kaplanek P, Tong A, Parsons AB, et al. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell (2005) 120:715-27. doi:10.1016/j.cell.2004.12.024
54. Jónsson ZO, Dhar SK, Narlikar GJ, Auty R, Wagle N, Pellman D, et al. Rvb1p and Rvb2p are essential components of a chromatin remodeling complex that regulates transcription of over 5% of yeast genes. J Biol Chem (2001) 276:16279-88. doi:10.1074/jbc.M011523200
55. Krogan NJ, Keogh MC, Datta N, Sawa C, Ryan OW, Ding H, et al. A Snf2 family ATPase complex required for recruitment of the histone H2A variant Htz1. Mol Cell (2003) 12:1565-76. doi:10.1016/S1097-2765(03)00497-0
56. Kobor MS, Venkatasubrahmanyam S, Meneghini MD, Gin JW, Jennings JL, Link AJ, et al. A protein complex containing the conserved Swi2/Snf2-related ATPase Swr1p deposits histone variant H2A.Z into euchromatin. PLoS Biol (2004) 2:e131. doi:10.1371/journal.pbio.0020131
57. Mizuguchi G, Shen X, Landry J, Wu WH, Sen S, Wu C. ATP-driven exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex. Science (2004) 303:343-8. doi:10.1126/science.1090701
58. Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell (2000) 102:463-73. doi:10.1016/S0092-8674(00)00051-9
59. Tariq M, Nussbaumer U, Chen Y, Beisel C, Paro R. Trithorax requires Hsp90 for maintenance of active chromatin at sites of gene expression. Proc Natl Acad Sci U S A (2009) 106:1157-62. doi:10.1073/pnas.0809669106
60. Iwasaki S, Kobayashi M, Yoda M, Sakaguchi Y, Katsuma S, Suzuki T, et al. Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes. Mol Cell (2010) 39:292-9. doi:10.1016/j.molcel.2010.05.015
61. Zhao R, Kakihara Y, Gribun A, Huen J, Yang G, Khanna M, et al. Molecular chaperone Hsp90 stabilizes Pih1/Nop17 to maintain R2TP complex activity that regulates snoRNA accumulation. J Cell Biol (2008) 180:563-78. doi:10.1083/jcb.200709061
62. Hamamoto R, Toyokawa G, Nakakido M, Ueda K, Nakamura Y. SMYD2-dependent HSP90 methylation promotes cancer cell proliferation by regulating the chaperone complex formation. Cancer Lett (2014) 351:126-33. doi:10.1016/j.canlet.2014.05.014
63. Li D, Marchenko ND, Moll UM. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis. Cell Death Differ (2011) 18:1904-13. doi:10.1038/cdd.2011.71
64. Zhang J, Xu E, Chen X. TAp73 protein stability is controlled by histone deacetylase 1 via regulation of Hsp90 chaperone function. J Biol Chem (2013) 288:7727-37. doi:10.1074/jbc.M112.429522
65. Sawarkar R, Sievers C, Paro R. Hsp90 globally targets paused RNA polymerase to regulate gene expression in response to environmental stimuli. Cell (2012) 149:807-18. doi:10.1016/j.cell.2012.02.061
66. Kim RH, Kim R, Chen W, Hu S, Shin K, Park N, et al. Association of Hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells. Carcinogenesis (2008) 29:2425-31. doi:10.1093/carcin/bgn225
67. Floer M, Bryant GO, Ptashne M. HSP90/70 chaperones are required for rapid nucleosome removal upon induction of the GAL genes of yeast. Proc Natl Acad Sci U S A (2008) 105:2975-80. doi:10.1073/pnas.0800053105
68. Freeman BC, Yamamoto KR. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science (2002) 296:2232-5. doi:10.1126/science.1073051